Murtaza Y. Dawood, MD

1997  B.S., Biochemistry, University of Maryland, College Park, MD
1997  B.S., Physiology & Neurobiology, University of Maryland, College Park, MD

2002  M.D., Saba University School of Medicine, Saba, Netherland-Antilles

2002-2008  Resident, General Surgery. NEOUCOM, Youngstown, OH

2008-2010  Resident, Cardiothoracic Surgery.  The Ohio State Univiersity, Columbus, OH

2010-2012  Fellow, Adult Structural Heart. University of Maryland School of Medicine, Baltimore, MD

Murtaza Dawood, MD, is a cardiac surgery at the University of Maryland School of Medicine.  Dr. Dawood also serves as the Surgical Co-Director of UMMC's Arrhythmia Program.  Dr. Dawood's interests include structural heart disease with a focus on valvular disease (endocarditis, degenerative) and atrial fibrillation.

Dr. Dawood is a strong proponent of the Heart Team model.  He operates as Primary Surgeon when performing Transcatheter Aortic Valve Replacement (TAVR) with our colleagues from Interventional Cardiology.   He is also an integral part of the trancatheter mitral therapies at UMMC (MitraClip, APOLLO Trial).

Dr. Dawood has brought the Hybrid Maze approach to the University of Maryland to treat patients with all forms of Atrial Fibrillation (AF).  This approach combines minimally invasive surgical ablations with endovascular ablations performed by our colleagues in Electrophysiology.

Atrial Fibrillation, TAVR, MitraClip, APOLLO, Endocarditis, Mitral Valve, Tricuspid Valve, AFib